• BACKGROUND
    • Concerns remain that thinner highly crosslinked polyethylene (HXLPE) liners in modern total hip arthroplasty (THA) may lead to premature liner-related failures or revision. The aim of this study was to evaluate the effect of liner thickness on survival and revision rates of HXLPE in primary THA after more than 10 years.
  • METHODS
    • We retrospectively identified 2,565 primary THAs using HXLPE with a mean follow-up of 13 years (range, 11 to 19). Patients were grouped for each mm of polyethylene thickness. Liner thickness varied from 4.9 to 12.7 mm, with one third measuring less than 6 mm. Primary outcomes were reoperation, all-cause revision, and liner-related revision.
  • RESULTS
    • The reoperation rate was 7.3%, the all-cause revision rate was 5.6%, and the liner-related revision rate was 0.04%. There was no significant difference in all-cause revision when stratified by liner thickness (P = .286) and liner thickness was not associated with liner-related revision (n = 1). There was a statistically, but not clinically significant difference in mean liner thickness for the cohort that underwent reoperation (7.09 versus 6.89 mm, P = .01) and all-cause revision (7.16 versus 6.89 mm, P = .031).
  • CONCLUSION
    • In our cohort, liner thickness was not associated with all-cause revision-free survival, and there was no clinically significant difference in liner thickness between those patients who did require a reoperation or all-cause revision, and those who did not. There was only 1 liner-related failure in the entire cohort. Our results indicate that using thinner HXLPE liners to maximize femoral head size in THA is a safe practice that does not lead to increased revision rates or liner failure at a mean 13-year follow-up.